Featuring:
Wayne Edward Rees, CEO
LED Dental Inc
Originally Broadcast on June 2, 2026
Company: LED Dental Inc, featuring VELscope®
Website link: https://velscope.com/
Continuing Education: No ASHA CEUs are offered for this webinar. A Certificate of Participation will be provided to those who complete the post-webinar survey.
Description: Bringing awareness to the escalating profile of oral and oropharyngeal cancers related to a common virus — According to the CDC, nearly all sexually active adults will have an HPV (Human papillomavirus) infection in their lifetime. This is fueling an escalating rise in the incidence of HPV-positive oropharyngeal cancer. By the year 2022, HPV-positive oropharyngeal cancer was expected to be the leading HPV-related cancer surpassing cervical cancer. The historic etiologic patterns related to exposure to alcohol and tobacco are declining, while HPV is becoming increasingly more common. What are the implications to dental profession and how should our oral cancer screening be adjusted to compensate for this new profile? How do we communicate this to today’s dental patient? High risk extraoral and intraoral anatomical areas will be reviewed as well as identifying the subtle life-saving signs that accompany oral and oropharyngeal cancer that are so often overlooked.
Learning Objectives:
- To review and understand the considerations of using the VELscope® in clinical practice.
- To further explore the current statistics related to the sexually transmitted Human papillomavirus and its connection with oral and oropharyngeal cancer
- To review clinic studies including new research to better understand the efficacy of the VELscope®.
- To work with the VELscope® and learn hands-on techniques to visualize oral mucosal abnormalities such as oral cancer or pre-malignant dysplasia.
- To better understand how VELscope® can assist a clinician in differentiating traumatic lesions from lesions of a more serious nature.
- To review how to capture white light and VELscope® Images for communication and documentation purposes.
Speaker: Wayne Rees is the CEO and co-founder for LED Dental Inc, the manufacturer of the VELscope Vx Oral Mucosal Screening System. He was responsible in his role for all aspects of commercialization, from financing, manufacturing, regulatory approval, to product launch and distribution. The VELscope is presently being marketed worldwide. Wayne has been involved in Dental Imaging for the past 30 years, co-developing and commercializing such products as PicturePerfect, InfoSource, Image F/X and CosmetiX, MedX for Medical Imaging and DICOM ImagExplorer and Simulator. Wayne was the Director of Dental Imaging for KODAK Dental and has consulted with Olympus on Dental Digital Photography and has lectured on Digital Dental Photography and Imaging internationally. He also served on the American Dental Association Standards Committee.
Disclosures:
Financial: CEO and co-founder of LED Dental, Inc, which is themanufacturer of the VELscope Vx Oral Mucosal Screening System
Non-Financial: None
Please note: The NFOSD is a nonprofit patient advocacy organization. We do not endorse specific products, treatments, or brands. The NFOSD does not provide person-specific medical advice or treatment recommendations. This presentation is for informational purposes only, and does not intend to substitute professional medical advice, diagnosis, or treatment. Never modify your treatment plan without consulting with your healthcare team. If you need assistance identifying a swallowing disorder specialist, please contact us at info@nfosd.com.